Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Timo Laurila"'
Autor:
Timo Laurila
Publikováno v:
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum.
Autor:
Timo Laurila
Publikováno v:
Forum Médical Suisse ‒ Swiss Medical Forum.
Publikováno v:
Seminars in Preventive and Alternative Medicine. 3:133-139
Publikováno v:
International Urology and Nephrology. 39:1163-1165
Seminoma of the testis has a diverse natural history. We report a unique case of histologically confirmed classic seminoma in a 32-year-old patient documented by ultrasound on two occasions one year apart. The tumor size did not change during that ti
Autor:
Dawn R. Church, Bing Yang, Joshua A. Desotelle, Wei Huang, David F. Jarrard, Timo Laurila, Jonathan A. Ewald
Publikováno v:
The Prostate. 73(4)
BACKGROUND The treatment of non-localized prostate cancer involves androgen deprivation (AD) therapy which results in tumor regression. Apoptosis has been implicated in the tumor response to AD, but constitutes a small fraction of the total tumor at
Publikováno v:
Urologic oncology. 31(6)
Active surveillance (AS) is an option for the management of favorable risk prostate cancer (CaP) in the PSA era. Published studies have reported variable inclusion criteria for cohort selection. Accurate assessment of individual patient risk in AS is
Publikováno v:
Journal of Urology. 185
Publikováno v:
Urologic oncology. 27(5)
Objective Robotic-assisted laparoscopic prostatectomy (RALP) is being increasingly utilized. To assess the efficacy of the operation, we compared apical and overall margin status for RALP with radical retropubic prostatectomy (RRP) in a group of cont
Publikováno v:
Journal of robotic surgery. 2(1)
The introduction of minimally invasive surgery for radical retropubic prostatectomy has increased the incidence of recognition of accessory pudendal arteries. Early identification and preservation of these vessels is paramount for optimal functional
Autor:
Annukka Paju, Timo Laurila, Kristina Hotakainen, Ulf-Håkan Stenman, Virgil Gadaleanu, Anders Bjartell, Yue Cao, Akseli Hemminki
Publikováno v:
European urology. 52(6)
Objectives Tumor-associated-trypsin inhibitor (TATI) is frequently coexpressed with trypsinogen in tumors. Recently, we found expression of trypsinogens in prostate cancer. We have now studied whether TATI is also expressed in prostate cancer and if